Lazard has been on fire lately. In the past six months alone, the company’s stock price has rocketed 40%, reaching $48.82 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Shares of financial advisory firm Lazard (NYSE:LAZ) jumped 3.3% in the afternoon session after analyst firm Keefe, Bruyette & Woods maintained its "Outperform" rating on the stock, signaling continued confidence. While the firm's analyst did lower the price target to $60.00 from $65.00, the market appeared to focus on the positive rating being upheld. This news followed a recent company update from a few days prior, where Lazard reported its preliminary assets under management (AUM) for September had risen to approximately $264.5 billion. The increase in AUM was attributed to market appreciation. The combination of the maintained positive analyst outlook and the recent growth in managed assets likely contributed to the stock's rise.
Shares of financial advisory firm Lazard (NYSE:LAZ) jumped 2.3% in the morning session after the company announced the appointment of Dr. Geoffrey Porges as a Managing Director in its Healthcare Advisory Group.
Wall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Wall Street's investment banking sector is experiencing a significant and widely anticipated rebound, signaling a renewed confidence across global financial markets. After a challenging period characterized by economic uncertainties and a slowdown in deal-making, the sector is now witnessing a robust surge in Mergers & Acquisitions (M&A) and Initial Public
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Goldman Sachs (NYSE:GS) and the rest of the investment banking & brokerage stocks fared in Q2.
Uncover the potential of LAZARD INC, a growth stock reasonably priced. NYSE:LAZ is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive valuation.
NYSE:LAZ is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.
Discover LAZARD INC, an undervalued growth gem. NYSE:LAZ is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing valuation.
